Gujarat Themis Biosyn Limited (GUJTHEM.NS)
- Previous Close
296.60 - Open
296.55 - Bid --
- Ask --
- Day's Range
280.00 - 305.10 - 52 Week Range
208.00 - 330.45 - Volume
144,158 - Avg. Volume
202,496 - Market Cap (intraday)
32.287B - Beta (5Y Monthly) -0.16
- PE Ratio (TTM)
58.88 - EPS (TTM)
4.81 - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Gujarat Themis Biosyn Limited engages in the manufacture of pharmaceuticals and medicinal chemicals in India. The company offers bulk drugs on job work basis in India. Its products include Rifamycin-S, an intermediate for the treatment of tuberculosis; Rifamycin-O; and Lovastatin. The company was incorporated in 1981 and is based in Mumbai, India.
www.gtbl.in159
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: GUJTHEM.NS
View MorePerformance Overview: GUJTHEM.NS
Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GUJTHEM.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GUJTHEM.NS
View MoreValuation Measures
Market Cap
30.91B
Enterprise Value
30.77B
Trailing P/E
58.67
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
19.92
Price/Book (mrq)
13.81
Enterprise Value/Revenue
19.84
Enterprise Value/EBITDA
40.61
Financial Highlights
Profitability and Income Statement
Profit Margin
33.96%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
1.55B
Net Income Avi to Common (ttm)
526.59M
Diluted EPS (ttm)
4.81
Balance Sheet and Cash Flow
Total Cash (mrq)
181.09M
Total Debt/Equity (mrq)
1.52%
Levered Free Cash Flow (ttm)
--